Cite
HARVARD Citation
Cheng, Y. et al. (n.d.). 103P Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of Chinese extensive-stage small cell lung cancer (ORIENTAL): Preliminary safety and efficacy results. Immuno-oncology technology. p. . [Online].